EBOS Group Ltd

Healthcare AU EBO

31.53AUD
-0.11(0.35%)

Last update at 2024-05-15T06:10:00Z

Day Range

31.0331.61
LowHigh

52 Week Range

30.5640.39
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 406.39M 327.37M 282.60M 246.23M 201.94M
Minority interest -10.96093M 0.63M -5.32100M -4.07300M -3.07100M
Net income 275.74M 224.64M 199.09M 173.95M 173.95M
Selling general administrative 578.28M 467.06M 382.43M 347.69M 357.61M
Selling and marketing expenses - - - - -
Gross profit 1698.92M 1380.71M 1066.34M 987.11M 846.26M
Reconciled depreciation 135.80M 90.78M 78.05M 78.29M 33.54M
Ebit 495.06M 365.49M 313.51M 276.32M 233.15M
Ebitda 630.86M 456.27M 391.57M 354.61M 266.69M
Depreciation and amortization 135.80M 90.78M 78.05M 78.29M 33.54M
Non operating income net other - - - - -
Operating income 483.20M 382.22M 308.56M 277.98M 233.15M
Other operating expenses 10402.47M 9496.65M 8072.80M 7684.13M 7012.38M
Interest expense 73.79M 25.44M 22.18M 25.32M 28.52M
Tax provision 119.69M 103.35M 84.85M 68.54M 56.29M
Interest income 9.30M 3.06M 0.77M 30.40M 25.33M
Net interest income -76.78855M -31.80508M -21.41184M -23.83603M -26.50555M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 119.69M 103.35M 84.85M 73.36M 58.89M
Total revenue 13317.45M 11901.67M 9888.13M 9381.93M 7250.85M
Total operating expenses 1199.92M 985.25M 748.81M 704.39M 607.80M
Cost of revenue 11618.53M 10520.96M 8821.80M 8394.82M 6404.58M
Total other income expense net -15.81891M -36.28673M -5.23155M -3.95483M -31.21050M
Discontinued operations - - - - -
Net income from continuing ops 286.70M 224.01M 197.75M 172.87M 143.05M
Net income applicable to common shares 253.37M 202.60M 185.30M 162.52M 137.70M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 7005.15M 6945.94M 4243.86M 4010.26M 3350.30M
Intangible assets 560.74M 267.56M 174.54M 177.99M 178.02M
Earning assets - - - - -
Other current assets 68.81M 58.27M 15.51M 15.81M 10.77M
Total liab 4498.50M 4560.36M 2733.49M 2607.21M 2053.73M
Total stockholder equity 2649.25M 2511.16M 1516.09M 1407.41M 1299.78M
Deferred long term liab - - - - -
Other current liab 620.43M 827.05M 438.54M 503.06M 169.62M
Common stock 2056.66M 2007.50M 1067.60M 1029.10M 974.90M
Capital stock 2056.66M 2007.50M 1067.60M 1029.10M 974.90M
Retained earnings 608.80M 534.06M 465.73M 398.17M 338.60M
Other liab 284.94M 327.90M 138.89M 140.11M 77.88M
Good will 2150.80M 2372.81M 1073.75M 1037.81M 990.85M
Other assets 208.60M 182.16M 141.84M 0.00000M 55.00M
Cash 230.59M 573.58M 181.53M 261.99M 174.33M
Cash and equivalents - - - - -
Total current liabilities 2892.65M 2784.82M 2017.81M 1891.89M 1591.37M
Current deferred revenue -98.61549M -416.90041M -163.86633M -299.73289M -
Net debt 1165.59M 1253.23M 549.45M 603.88M 382.64M
Short term debt 100.41M 414.84M 164.54M 300.51M 176.09M
Short long term debt 45.84M 367.58M 125.33M 264.28M 176.09M
Short long term debt total 1396.17M 1826.82M 730.98M 865.87M 556.96M
Other stockholder equity -2657.77601M -2534.04824M -1530.97452M -1425.06670M -13.11500M
Property plant equipment 660.67M 576.98M 464.94M 402.42M 180.97M
Total current assets 3272.26M 3398.00M 2282.85M 2161.87M 1881.39M
Long term investments 58.39M 65.86M 60.77M 61.28M 53.16M
Net tangible assets -57.24000M -116.53900M 249.24M 179.03M 125.12M
Short term investments 14.73M 17.02M -0.09330M -0.09459M -
Net receivables 1629.69M 1524.26M 1242.61M 1094.50M 939.31M
Long term debt 1018.99M 1160.06M 347.66M 324.92M 364.04M
Inventory 1343.17M 1241.88M 843.19M 789.57M 756.98M
Accounts payable 2270.42M 1959.83M 1578.60M 1388.05M 1245.66M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -16.21395M -30.39805M -17.23971M -19.85551M -13.72149M
Additional paid in capital - - - - -
Common stock total equity - - - 1029.10M 974.90M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 19.17M 1.51M 0.03M 0.35M 0.68M
Deferred long term asset charges - - - - -
Non current assets total 3732.89M 3547.94M 1961.01M 1848.40M 1468.91M
Capital lease obligations 331.34M 299.18M 258.00M 253.82M -
Long term debt total - - 527.19M 528.22M 364.04M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -167.88007M -7.89600M -0.49700M -3.55100M -0.11000M
Change to liabilities 270.73M 414.97M 209.62M 115.64M 118.65M
Total cashflows from investing activities -154.26500M -1396.19700M -113.76300M -73.33100M -120.05300M
Net borrowings -450.61700M 864.52M -167.12000M 7.44M -51.87800M
Total cash from financing activities -595.41952M 1664.95M -279.33383M -79.97645M 17.12M
Change to operating activities 20.56M 117.91M 9.94M 19.19M 0.67M
Net income 274.94M 223.98M 198.79M 173.68M 144.07M
Change in cash -332.38655M 386.25M -81.47094M 83.65M 17.53M
Begin period cash flow 562.97M 187.33M 263.00M 178.34M 156.80M
End period cash flow 230.59M 573.58M 181.53M 261.99M 174.33M
Total cash from operating activities 424.69M 274.98M 320.03M 244.93M 124.02M
Issuance of capital stock 86.21M 877.27M 34.52M 31.76M 175.95M
Depreciation 135.41M 90.51M 77.93M 78.17M 33.54M
Other cashflows from investing activities - - -31.50300M -44.05000M -85.85200M
Dividends paid -191.23953M -170.87260M -134.29247M -119.69817M 104.55M
Change to inventory -141.34997M -352.88971M -50.48860M -15.15585M -188.43500M
Change to account receivables -133.93751M -240.55145M -143.66219M -133.36015M 19.07M
Sale purchase of stock 26.05M 1287.16M 53.29M 43.49M 168.18M
Other cashflows from financing activities -53.30613M -45.39417M -37.88654M -34.20422M 24.14M
Change to netincome 15.58M -20.04200M -18.20500M -4.85800M -2.58900M
Capital expenditures 107.03M 99.38M 88.39M 31.34M 35.78M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -275.28749M -593.44116M -194.15079M -148.51600M 3.32M
Stock based compensation 9.78M 6.93M 4.02M 2.85M -
Other non cash items 14.34M -39.51152M 43.31M -6.91642M -177.61142M
Free cash flow 317.66M 175.59M 231.65M 213.59M 88.24M

Fundamentals

  • Previous Close 31.64
  • Market Cap6021.29M
  • Volume41964
  • P/E Ratio23.51
  • Dividend Yield2.99%
  • EBITDA533.80M
  • Revenue TTM12674.17M
  • Revenue Per Share TTM66.17
  • Gross Profit TTM 1547.46M
  • Diluted EPS TTM1.33

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EBO
EBOS Group Ltd
-0.11 0.35% 31.53 23.51 22.99 0.49 2.63 0.55 12.04
SIG
Sigma Pharmaceuticals Ltd
0.01 0.81% 1.25 - 75.19 0.62 2.39 0.55 34.94
PGC
Paragon Care Ltd
-0.005 1.39% 0.35 18.00 6.12 0.70 0.88 1.09 10.59

Reports Covered

Stock Research & News

Profile

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

EBOS Group Ltd

737 Bourke Street, Docklands, VIC, Australia, 3008

Key Executives

Name Title Year Born
Mr. John Cullity Chief Exec. Officer NA
Mr. Leonard Hansen CFO & Chief Accountant NA
Ms. Andrea Bell Chief Information Officer NA
Martin Krauskopf Exec. GM of Strategy, Mergers & Acquisitions and GM of Investor Relations NA
Ms. Janelle Cain Gen. Counsel NA
Ms. Jacinta McCarthy Group Gen. Mang. of HR NA
Mr. Simon Bunde Exec. Gen. Mang. of Strategic Operations, ESG & Innovation NA
Ms. Julie Dillon Chief Exec. Officer of Animal Care NA
Mr. Matthew Muscio Chief Exec. Officer of Medical Technology NA
Mr. Brett Barons Chief Exec. Officer of Symbion NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).